CRISPR Therapeutics (CRSP) Institutional Ownership $43.78 -1.62 (-3.57%) (As of 12/13/2024 ET) Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for CRISPR Therapeutics (NASDAQ:CRSP)CurrentInstitutional OwnershipPercentage69.20%Number ofInstitutional Buyers(last 12 months)229TotalInstitutional Inflows(last 12 months)$635.14MNumber ofInstitutional Sellers(last 12 months)110TotalInstitutional Outflows(last 12 months)$243.49M Get CRSP Insider Trade Alerts Want to know when executives and insiders are buying or selling CRISPR Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data CRSP Institutional Buying and Selling by Quarter Ad Weiss RatingsBitcoin just crossed $100,000 … how high will it go?Bitcoin just broke the $100,000 barrier for the first time in its history. Just as America's top crypto expert, Juan Villaverde, predicted. In fact, on DATE, Juan said Bitcoin would cross $100,000 before inauguration. Now he thinks it could reach $125,000 by the end of Trump's first month in office.It's set up perfectly for this historic bull run. CRISPR Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails11/27/2024 Franklin Resources Inc.7,097$339K0.0%+12.7%0.008% 11/25/2024 Wilmington Savings Fund Society FSB850$40K0.0%N/A0.001% 11/25/2024 Sanctuary Advisors LLC8,317$398K0.0%+17.8%0.010% 11/20/2024 Westside Investment Management Inc.6,442$308K0.1%-13.7%0.008% 11/20/2024 Virtu Financial LLC7,734$363K0.0%-22.2%0.009% 11/18/2024 Arete Wealth Advisors LLC10,376$486K0.0%-3.6%0.012% Get the Latest News and Ratings for CRSP and Related StocksEnter your email address below to receive the latest news and analysts' ratings for CRISPR Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 11/18/2024 Sunbelt Securities Inc.2,955$139K0.0%+11.3%0.003% 11/16/2024 Geode Capital Management LLC1,008,214$47.38M0.0%+3.6%1.181% 11/15/2024 Main Management ETF Advisors LLC14,744$693K0.0%N/A0.017% 11/15/2024 XTX Topco Ltd30,022$1.41M0.1%+294.0%0.035% 11/15/2024 State Street Corp2,992,988$140.61M0.0%+25.0%3.507% 11/15/2024 Stifel Financial Corp40,237$1.89M0.0%-20.2%0.047% 11/15/2024 Readystate Asset Management LP7,153$336K0.0%N/A0.008% 11/15/2024 Reynders McVeigh Capital Management LLC119,586$5.62M0.3%+4.3%0.140% 11/15/2024 HighTower Advisors LLC38,316$1.79M0.0%-3.4%0.045% 11/15/2024 Benjamin Edwards Inc.32,703$1.54M0.0%+13,640.8%0.038% 11/15/2024 Baker BROS. Advisors LP843,075$39.61M0.4%+743.1%0.988% 11/14/2024 Bellevue Group AG610,000$28.66M0.5%-1.2%0.715% 11/14/2024 Captrust Financial Advisors31,712$1.49M0.0%+32.0%0.037% 11/14/2024 Rockefeller Capital Management L.P.92,867$4.36M0.0%-1.2%0.109% 11/14/2024 UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC676,326$31.77M0.0%-2.5%0.792% 11/13/2024 Freedom Investment Management Inc.8,161$383K0.0%-5.0%0.010% 11/13/2024 BNP Paribas Financial Markets87,956$4.13M0.0%-35.5%0.103% 11/13/2024 FMR LLC2,376,166$111.63M0.0%+1.0%2.784% 11/13/2024 The Manufacturers Life Insurance Company 12,477$586K0.0%+1.9%0.015% 11/13/2024 Horizon Kinetics Asset Management LLC10,239$481K0.0%-4.1%0.012% 11/13/2024 Loomis Sayles & Co. L P945,267$44.41M0.1%-6.1%1.108% 11/13/2024 Boston Family Office LLC9,763$459K0.0%+2.2%0.011% 11/13/2024 Bedell Frazier Investment Counselling LLC26,357$1.24M0.3%+0.8%0.031% 11/13/2024 Independent Advisor Alliance7,719$363K0.0%+29.2%0.009% 11/12/2024 SevenBridge Financial Group LLC6,076$285K0.1%+7.5%0.007% 11/12/2024 Charles Schwab Investment Management Inc.724,241$34.03M0.0%+0.9%0.849% 11/8/2024 Darwin Wealth Management LLC925$43K0.0%N/A0.001% 11/8/2024 Advisors Asset Management Inc.9,669$454K0.0%+3.7%0.011% 11/8/2024 Banque Cantonale Vaudoise17,111$804K0.0%-1.5%0.020% 11/7/2024 Swiss National Bank157,600$7.40M0.0%-0.7%0.185% 11/7/2024 Thrivent Financial for Lutherans47,696$2.24M0.0%+1.0%0.056% 11/6/2024 Natixis Advisors LLC10,042$472K0.0%-7.9%0.012% 11/6/2024 Curi RMB Capital LLC46,715$2.20M0.0%+19.4%0.055% 11/6/2024 KBC Group NV2,818$132K0.0%+43.9%0.003% URGENT: This Altcoin Opportunity Won’t Wait – Act Now (Ad)Crypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year. This is where fortunes are made – often LITERALLY overnight.>> Register for the Workshop Now11/6/2024 Bouvel Investment Partners LLC21,703$1.02M0.4%-1.0%0.026% 11/6/2024 Oppenheimer & Co. Inc.34,128$1.60M0.0%+7.8%0.040% 11/5/2024 Aigen Investment Management LP6,335$298K0.1%N/A0.007% 11/5/2024 Sumitomo Mitsui Trust Group Inc.2,968,034$139.44M0.1%-5.8%3.490% 11/5/2024 Baillie Gifford & Co.364,768$17.14M0.0%-10.0%0.429% 11/5/2024 Entropy Technologies LP7,905$371K0.0%-48.7%0.009% 11/4/2024 Venturi Wealth Management LLC1,700$80K0.0%-29.2%0.002% 11/4/2024 State of New Jersey Common Pension Fund D40,341$1.90M0.0%+16.8%0.047% 11/4/2024 Axxcess Wealth Management LLC10,271$483K0.0%+3.3%0.012% 11/2/2024 Privium Fund Management B.V.30,347$1.43M0.4%+11.0%0.036% 11/1/2024 Leavell Investment Management Inc.5,700$268K0.0%-54.9%0.007% 10/31/2024 ARK Investment Management LLC7,498,625$352.29M3.2%-3.6%8.830% 10/29/2024 Van ECK Associates Corp1,546$71K0.0%-98.1%0.002% 10/29/2024 Capital Advisors Inc. OK300,589$14.12M0.3%+8.1%0.354% 10/28/2024 EMC Capital Management3,330$156K0.1%-64.2%0.004% 10/28/2024 US Bancorp DE2,589$122K0.0%-55.5%0.003% 10/28/2024 Congress Asset Management Co.65,768$3.09M0.0%+2.8%0.077% 10/28/2024 HM Payson & Co.2,330$109K0.0%+115.7%0.003% 10/25/2024 SteelPeak Wealth LLC10,183$478K0.0%-35.0%0.012% 10/25/2024 Pinnacle Associates Ltd.3,993$188K0.0%N/A0.005% 10/25/2024 China Universal Asset Management Co. Ltd.16,381$770K0.1%+64.2%0.019% 10/25/2024 SFE Investment Counsel6,312$297K0.1%+8.0%0.007% 10/24/2024 Patriot Financial Group Insurance Agency LLC29,586$1.39M0.2%+7.9%0.035% 10/24/2024 Farrow Financial Inc.19,827$931K0.6%+14.2%0.023% 10/24/2024 Wealth Enhancement Advisory Services LLC30,241$1.42M0.0%-5.2%0.036% 10/24/2024 PFG Investments LLC9,651$453K0.0%-7.3%0.011% 10/24/2024 Arkadios Wealth Advisors11,295$531K0.0%+4.9%0.013% 10/23/2024 Mirae Asset Global Investments Co. Ltd.3,080$146K0.0%+21.5%0.004% 10/23/2024 Allworth Financial LP680$32K0.0%-71.7%0.001% 10/23/2024 Hennion & Walsh Asset Management Inc.40,568$1.91M0.1%+15.9%0.048% 10/22/2024 International Assets Investment Management LLC38,852$1.83M0.0%N/A0.046% 10/22/2024 Private Advisor Group LLC71,747$3.37M0.0%-7.6%0.084% 10/22/2024 Eastern Bank1,500$70K0.0%N/A0.002% 10/22/2024 Sequoia Financial Advisors LLC4,795$225K0.0%-52.4%0.006% 10/18/2024Slow Capital Inc.85,910$4.04M0.6%+8.5%0.101% 10/18/2024Blue Trust Inc.3,844$181K0.0%+158.7%0.005% 10/18/2024Stratos Wealth Advisors LLC5,442$256K0.0%-20.1%0.006% 10/17/2024 Harbour Capital Advisors LLC8,925$405K0.1%-3.8%0.011% 10/16/2024 nVerses Capital LLC5,500$258K0.1%N/A0.006% 10/16/2024 IQ EQ FUND MANAGEMENT IRELAND Ltd13,617$640K0.1%+56.4%0.016% 10/16/2024 Vontobel Holding Ltd.16,957$797K0.0%+3.7%0.020% 10/11/2024 Creative Planning13,671$642K0.0%-7.3%0.016% 10/10/2024 Exchange Traded Concepts LLC19,192$902K0.0%+22.8%0.023% 10/8/2024 CWM LLC19,254$905K0.0%-14.0%0.023% 10/7/2024 Green Alpha Advisors LLC19,158$900K0.7%-2.4%0.023% 10/5/2024 Handelsbanken Fonder AB29,100$1.37M0.0%-71.0%0.034% 10/3/2024 SG Americas Securities LLC25,711$1.21M0.0%-1.8%0.030% 9/5/2024 Sanctuary Advisors LLC7,059$381K0.0%N/A0.008% 8/22/2024 Cetera Investment Advisers26,838$1.45M0.0%-21.3%0.032% 8/21/2024 Granite Bay Wealth Management LLC41,096$2.38M0.1%N/A0.048% Top Picks for Trump’s Pro-Crypto America (Ad)Coins Set to Soar with a Pro-Crypto White House President-Elect Donald Trump is reported to be holding over $3 Million worth of crypto – and he's not the only one at the top interested in digital assets…Click here to reserve your free seat at the Crypto Community Summit8/19/2024B. Riley Wealth Advisors Inc.8,867$479K0.0%-47.3%0.010% 8/16/2024 Sunbelt Securities Inc.2,655$143K0.0%+23.2%0.003% 8/16/2024 Northwestern Mutual Wealth Management Co.4,606$249K0.0%+4.8%0.005% 8/16/2024 Creative Planning14,750$797K0.0%+3.2%0.017% 8/16/2024 Algert Global LLC12,342$667K0.0%+45.0%0.015% 8/15/2024 Susquehanna Portfolio Strategies LLC5,845$316K0.0%-84.3%0.007% 8/15/2024 Scientech Research LLC24,323$1.31M0.3%+181.6%0.029% 8/15/2024 The Manufacturers Life Insurance Company12,246$661K0.0%-39.9%0.014% 8/15/2024 Armistice Capital LLC198,357$10.71M0.1%+3.3%0.234% 8/14/2024 Marshall Wace LLP186,591$10.08M0.0%N/A0.220% (Data available from 1/1/2016 forward) CRSP Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of CRSP shares? During the previous two years, 361 institutional investors and hedge funds held shares of CRISPR Therapeutics. The most heavily invested institutionals were Capital International Investors ($534.18M), ARK Investment Management LLC ($352.29M), Nikko Asset Management Americas Inc. ($222.70M), Sumitomo Mitsui Trust Holdings Inc. ($170.21M), State Street Corp ($140.61M), Sumitomo Mitsui Trust Group Inc. ($139.44M), and FMR LLC ($111.63M).Learn more on CRSP's institutional investors. What percentage of CRISPR Therapeutics stock is owned by institutional investors? 69.20% of CRISPR Therapeutics stock is owned by institutional investors. Learn more on CRSP's institutional investor holdings. Which institutional investors have been buying CRISPR Therapeutics stock? Of the 309 institutional investors that purchased CRISPR Therapeutics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Capital International Investors ($1.80M), ARK Investment Management LLC ($1.53M), SR One Capital Management LP ($1.05M), Baker BROS. Advisors LP ($743.08K), Marshall Wace LLP ($643.60K), Norges Bank ($617.59K), and State Street Corp ($599.30K). How much institutional buying is happening at CRISPR Therapeutics? Institutional investors have bought a total of 15,219,763 shares in the last 24 months. This purchase volume represents approximately $870.92M in transactions. Which CRISPR Therapeutics major shareholders have been selling company stock? Of the 171 institutional investors that sold CRISPR Therapeutics stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: ARK Investment Management LLC ($1.89M), Sumitomo Mitsui Trust Holdings Inc. ($1.11M), Armistice Capital LLC ($644.01K), Nikko Asset Management Americas Inc. ($487.28K), Allspring Global Investments Holdings LLC ($346.18K), Bellevue Group AG ($288.60K), and Price T Rowe Associates Inc. MD ($264.11K). How much institutional selling is happening at CRISPR Therapeutics? Institutional investors have sold a total of 8,176,985 shares in the last 24 months. This volume of shares sold represents approximately $438.81M in transactions. Related Companies Moderna Major Shareholders Neurocrine Biosciences Major Shareholders Bio-Techne Major Shareholders Vaxcyte Major Shareholders Qiagen Major Shareholders Exelixis Major Shareholders Repligen Major Shareholders Revolution Medicines Major Shareholders Halozyme Therapeutics Major Shareholders Krystal Biotech Major Shareholders This page (NASDAQ:CRSP) was last updated on 12/14/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowIt’s here. This is the moment we’ve been waiting for. The next 3-6 months in crypto will be absolutely life...Crypto Swap Profits | SponsoredWall Street Icon: “If you wait on this, it will already be too late”...Investing legend Louis Navellier warned us about the stock market crash of 1987... the 2000 dot-com crash… Enr...InvestorPlace | SponsoredA British Madness in AmericaWarren Buffett offloaded nearly 70% of his Apple holdings. They know, as I do, The Big AI Die Up is coming....Porter & Company | SponsoredPrepare Now Before This Looming $2 Trillion D.C. ShockMillions of traders could get blindsided by this election-year shock on December 18th… And if you do nothin...Timothy Sykes | SponsoredMedia Is Mocking Elon, But Wait Until They See This DemoElon Musk believes his new AI product will be worth an incredible $9 trillion. But the mainstream media is ...Brownstone Research | Sponsored⭕ [URGENT] Buy Alert just triggeredMy absolute favorite stock just hit a critical "buy now" trigger price.Behind the Markets | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CRISPR Therapeutics AG Please log in to your account or sign up in order to add this asset to your watchlist. Share CRISPR Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.